Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to George Bakris

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bakris, George

Item TypeName
Concept Renal Insufficiency, Chronic
Academic Article Beta blockers in the management of chronic kidney disease.
Academic Article Obesity and insulin resistance as risk factors for chronic kidney disease.
Academic Article Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
Academic Article Glycemic control and cardiovascular disease in chronic kidney disease.
Academic Article Overview of the KEEP international articles.
Academic Article Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
Academic Article Chronic kidney disease: a coronary heart disease equivalent?
Academic Article KEEP launches follow-up initiative aimed at predicting the future.
Academic Article Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?
Academic Article Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular risk.
Academic Article Diabetes, the kidney, and cardiovascular risk. Preface.
Academic Article Assessment and management of vascular disease risk in patients with chronic kidney disease.
Academic Article Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.
Academic Article Intensive blood-pressure control in hypertensive chronic kidney disease.
Academic Article Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.
Academic Article Association of BP variability with mortality among African Americans with CKD.
Academic Article A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.
Academic Article Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
Academic Article Noninsulin glucose-lowering agents for the treatment of patients on dialysis.
Academic Article Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).
Academic Article KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD.
Academic Article The author replies.
Academic Article Chronic kidney disease as a coronary artery disease risk equivalent.
Academic Article Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
Academic Article Diabetic kidney disease: a report from an ADA Consensus Conference.
Academic Article Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.
Academic Article Chronic kidney disease: optimal blood pressure for kidney disease-lower is not better.
Academic Article Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.
Academic Article Prediction and management of hyperkalemia across the spectrum of chronic kidney disease.
Academic Article Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
Academic Article Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Academic Article Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly.
Academic Article Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
Academic Article Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
Academic Article Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.
Academic Article New agents for hyperkalemia.
Academic Article Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease.
Academic Article Advances in treatment of hyperkalemia in chronic kidney disease.
Academic Article Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.
Academic Article The double challenge of resistant hypertension and chronic kidney disease.
Academic Article Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?
Academic Article Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
Academic Article Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.
Academic Article Mineralocorticoid antagonists in chronic kidney disease.
Academic Article The Kidney in Hypertension.
Academic Article Renal Targeted Therapies of Antihypertensive and Cardiovascular Drugs for Patients With Stages 3 Through 5d Kidney Disease.
Academic Article Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.
Academic Article Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Diabetes Mellitus and Chronic Kidney Disease: Turning the Page.
Academic Article Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
Academic Article Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.
Academic Article Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.
Academic Article Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.
Academic Article Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.
Academic Article MY APPROACH to the elderly patient with resistant hypertension.
Academic Article Consequences of Overinterpreting Serum Creatinine Increases when Achieving BP Reduction: Balancing Risks and Benefits of BP Reduction in Hypertension.
Academic Article Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.
Academic Article Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Academic Article Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy.
Academic Article Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.
Academic Article Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial.
Academic Article Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
Academic Article How to Manage Hypertension in People With Diabetes.
Academic Article Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease.
Academic Article Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD Trial.
Academic Article Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?
Academic Article Evolution of Patiromer Use: a Review.
Academic Article Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial.
Academic Article Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.
Academic Article Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Academic Article Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
Academic Article U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy.
Academic Article Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.
Academic Article Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial.
Academic Article Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial.
Academic Article Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.
Academic Article Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study.
Academic Article Intersection Between Chronic Kidney Disease and Cardiovascular Disease.
Academic Article Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
Academic Article Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Academic Article Response by Filippatos et al to Letter Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes".
Academic Article Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.
Academic Article Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial.
Academic Article An evaluation of KBP-5074 in advanced chronic kidney disease with uncontrolled hypertension.
Academic Article Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
Academic Article Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
Academic Article Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
Academic Article DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
Academic Article 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.
Academic Article Kidney function assessment and endpoint ascertainment in clinical trials.
Academic Article Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review.
Academic Article Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
Academic Article Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Academic Article Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design.
Academic Article Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial.
Academic Article Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes.
Academic Article Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial.
Academic Article Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure.

Search Criteria
  • Renal Insufficiency Chronic